The Accelerated Cure Project for Multiple Sclerosis (ACP) has launched a new community-led initiative designed to ensure that people from underrepresented multiple sclerosis (MS) communities help set priorities for future MS research. sp The initiative, called Prioritized Research Agenda Development and Advancement (PRADA), creates a…
MS research
Bazedoxifene, a medication that alters the activity of the sex hormone estrogen, was safe and well-tolerated but did not promote myelin repair in women with multiple sclerosis (MS) in a Phase 2 clinical trial. The findings come from the ReWRAP study (NCT04002934) and were presented last week at…
Researchers and clinicians are gathering in San Diego and online for the 11th annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, a three-day meeting focused on multiple sclerosis (MS) research and care. ACTRIMS 2026, being held Feb. 5-7 at the Marriott Marquis San Diego…
When immune B-cells mistakenly recognize the body’s own nerve tissue, they can shut themselves down to prevent damage, but infection with the Epstein-Barr virus (EBV) can trick B-cells into surviving and becoming activated in the brain instead of being eliminated by normal immune safety mechanisms, according to a study.
Recommended Posts
- Fenebrutinib again bests Aubagio in trial at cutting MS relapse rates
- I don’t have to be an Olympic medalist to achieve remarkable things
- New study links specific MRI lesion pattern to MS risk before symptoms
- With MS, parenting a teenager can get a little bloody — for dad
- Foralumab reduces microglial activity, inflammation in nonactive SPMS